102 related articles for article (PubMed ID: 15573865)
1. Selective retinoic acid receptor ligands for rheumatoid arthritis.
Beehler BC; Brinckerhoff CE; Ostrowski J
Curr Opin Investig Drugs; 2004 Nov; 5(11):1153-7. PubMed ID: 15573865
[TBL] [Abstract][Full Text] [Related]
2. RAR and RXR modulation in cancer and metabolic disease.
Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642
[TBL] [Abstract][Full Text] [Related]
3. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
de Lera AR; Bourguet W; Altucci L; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
[TBL] [Abstract][Full Text] [Related]
4. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic applications for ligands of retinoid receptors.
Thacher SM; Vasudevan J; Chandraratna RA
Curr Pharm Des; 2000 Jan; 6(1):25-58. PubMed ID: 10637371
[TBL] [Abstract][Full Text] [Related]
6. N-retinoyl-D-glucosamine, a new retinoic acid agonist, mediates topical retinoid efficacy with no irritation on photoaged skin.
Kambayashi H; Odake Y; Takada K; Funasaka Y; Ichihashi M; Kato S
Br J Dermatol; 2005 Dec; 153 Suppl 2():30-6. PubMed ID: 16280019
[TBL] [Abstract][Full Text] [Related]
7. Retinoids directly activate the collagen X promoter in prehypertrophic chondrocytes through a distal retinoic acid response element.
Cohen AJ; Lassová L; Golden EB; Niu Z; Adams SL
J Cell Biochem; 2006 Sep; 99(1):269-78. PubMed ID: 16598786
[TBL] [Abstract][Full Text] [Related]
8. Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors.
García J; Khanwalkar H; Pereira R; Erb C; Voegel JJ; Collette P; Mauvais P; Bourguet W; Gronemeyer H; de Lera AR
Chembiochem; 2009 May; 10(7):1252-9. PubMed ID: 19343742
[TBL] [Abstract][Full Text] [Related]
9. Synthetic retinoids: recent developments concerning structure and clinical utility.
Kagechika H; Shudo K
J Med Chem; 2005 Sep; 48(19):5875-83. PubMed ID: 16161990
[No Abstract] [Full Text] [Related]
10. Selective RXR modulators for the treatment of type II diabetes.
Faul MM; Grese TA
Curr Opin Drug Discov Devel; 2002 Nov; 5(6):974-85. PubMed ID: 12478728
[TBL] [Abstract][Full Text] [Related]
11. Retinoids: potential in cancer prevention and therapy.
Clarke N; Germain P; Altucci L; Gronemeyer H
Expert Rev Mol Med; 2004 Nov; 6(25):1-23. PubMed ID: 15569396
[TBL] [Abstract][Full Text] [Related]
12. 13-cis-retinoic acid alters the cellular morphology of slice-cultured serotonergic neurons in the rat.
Ishikawa J; Sutoh C; Ishikawa A; Kagechika H; Hirano H; Nakamura S
Eur J Neurosci; 2008 May; 27(9):2363-72. PubMed ID: 18445226
[TBL] [Abstract][Full Text] [Related]
13. Marked improvement induced in photoaged skin of hairless mouse by ER36009, a novel RARgamma-specific retinoid, but not by ER35794, an RXR-selective agonist.
Sakuta T; Kanayama T
Int J Dermatol; 2006 Nov; 45(11):1288-95. PubMed ID: 17076708
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid receptor modulators: a perspective on recent advances and promises.
Alvarez S; Bourguet W; Gronemeyer H; de Lera AR
Expert Opin Ther Pat; 2011 Jan; 21(1):55-63. PubMed ID: 21091043
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review.
Marchwicka A; Cunningham A; Marcinkowska E; Brown G
Expert Opin Ther Pat; 2016 Aug; 26(8):957-71. PubMed ID: 27336223
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid receptor gamma activates receptor tyrosine kinase Tie1 gene transcription through transcription factor GATA4 in F9 stem cells.
Su D; Gudas LJ
Exp Hematol; 2008 May; 36(5):624-41. PubMed ID: 18439490
[TBL] [Abstract][Full Text] [Related]
17. Retinoids for the treatment of psoriasis: outlook for the future.
Kuenzli S; Saurat JH
Curr Opin Investig Drugs; 2001 May; 2(5):625-30. PubMed ID: 11569936
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials with retinoids for breast cancer chemoprevention.
Zanardi S; Serrano D; Argusti A; Barile M; Puntoni M; Decensi A
Endocr Relat Cancer; 2006 Mar; 13(1):51-68. PubMed ID: 16601279
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cutaneous T-cell lymphoma with retinoids.
Zhang C; Duvic M
Dermatol Ther; 2006; 19(5):264-71. PubMed ID: 17014481
[TBL] [Abstract][Full Text] [Related]
20. Screening and detection of the in vitro agonistic activity of xenobiotics on the retinoic acid receptor.
Kamata R; Shiraishi F; Nishikawa J; Yonemoto J; Shiraishi H
Toxicol In Vitro; 2008 Jun; 22(4):1050-61. PubMed ID: 18289828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
